mevalonic acid has been researched along with Immunologic Deficiency Syndromes in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bonneville, M; Catros, V; Léger, A; Robard, M; Santolaria, T; Scotet, E | 1 |
1 other study(ies) available for mevalonic acid and Immunologic Deficiency Syndromes
Article | Year |
---|---|
Repeated systemic administrations of both aminobisphosphonates and human Vγ9Vδ2 T cells efficiently control tumor development in vivo.
Topics: Adenocarcinoma; Animals; Cell Line, Tumor; Diphosphonates; Drug Administration Schedule; Humans; Immunologic Deficiency Syndromes; Immunotherapy, Adoptive; Lymphocyte Activation; Male; Mevalonic Acid; Mice; Mice, Mutant Strains; Mice, SCID; Pamidronate; Prostatic Neoplasms; Receptors, Antigen, T-Cell, gamma-delta; T-Lymphocyte Subsets; Xenograft Model Antitumor Assays | 2013 |